Surbhi Sarna
Surbhi Sarna is the CEO and founder of Collate, an AI platform that creates and streamlines documentation for life sciences companies. She previously founded nVision Medical, a diagnostic company focused on early detection of ovarian cancer that was acquired by Boston Scientific in 2018 for $275 million. She also served as a General Partner at Y Combinator for over four years, leading their healthcare practice, and is the author of the book Without a Doubt, published by Simon & Schuster in 2023.
“Collate raised $95 million at a $1 billion valuation from Redpoint Ventures... AI documentation platform for life sciences companies.”
Source→“Collate raised $95 million at a $1 billion valuation from Redpoint Ventures... AI documentation platform for life sciences companies.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.